Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 2/20 | 0.81 |
| ▸ | MAOB | P27338 | 2/20 | 0.81 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.81 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.81 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.81 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.81 |
| ▸ | BACE1 | P56817 | 14/20 | 0.64 |
| ▸ | TYR | P14679 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | F3 | P13726 | 1/20 | 0.62 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.62 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1646481 | 1.00 | AKR1B1 (0.81) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL2574140 | 0.90 | AKR1B1 (1.00) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL428638 | 0.90 | AKR1B1 (1.00) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL28163045 | 0.88 | AKR1B1 (0.96) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| SCHEMBL10005951 | 0.85 | MAOB (0.81) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| SCHEMBL10350416 | 0.85 | RAB9A (0.62) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| SCHEMBL10351280 | 0.84 | CYP1A2 (0.63) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| SCHEMBL16702807 | 0.83 | AKR1B1 (0.85) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| SCHEMBL1650908 | 0.83 | HAO1 (0.70) | AKR1B1MAOBAKR1B10PTGS2GLO1 | |
| SCHEMBL16702808 | 0.83 | AKR1B1 (0.85) | AKR1B1MAOBAKR1B10PTGS2GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084641-A | Preparation method of demethoxycurcumin | 肇庆巨元生化有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118084641-A | Preparation method of demethoxycurcumin | 肇庆巨元生化有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-8962674-B2 | Curcumin derivative | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2015-02-24 | — | — | US | disclosed |
| US-8552220-B2 | Therapeutic agent for Alzheimer's disease | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2013-10-08 | — | — | US | disclosed |
| US-20110082295-A1 | NOVEL CURCUMIN DERIVATIVE | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2011-04-07 | — | — | US | disclosed |
| EP-2305629-A1 | THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE | Tokyo Institute of Technology (JP) | 2011-04-06 | — | — | EP | disclosed |
| US-20100048901-A1 | NOVEL CURCUMIN DERIVATIVE | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2123637-A1 | NOVEL CURCUMIN DERIVATIVE | Tokyo Institute of Technology (JP) | 2009-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048901-A1 | NOVEL CURCUMIN DERIVATIVE | BACE1, APP, BACE2 | AKR1B1 1096/4885MAOB 969/4885AKR1B10 1428/4885 |
| US-20110082295-A1 | NOVEL CURCUMIN DERIVATIVE | BACE1, APP, BACE2 | AKR1B1 1772/4885MAOB 1215/4885AKR1B10 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.